Get Started

COYA

NASD Coya Therapeutics, Inc.
Nov 5, 2026 · 12:09 AM ET EOD Market Closed

$3.08 ↑ +0.00 (+0.00%) Trading Up from the previous close of $3.08, $0.32 below the day’s high of $3.40

YTD change
-46.90%
vs 20-day SMA
-26.31%
vs 200-day SMA
-33.51%

Price ranges

Previous day
$3.03 $3.41
open $3.26 close $3.11
-$0.15 (-4.60%)
Today
$2.98 $3.40
open $3.17 now $3.08
-$0.09 (-2.84%)
Past week
$3.03 $4.20
from $4.12 now $3.08
-$1.04 (-25.24%)
Past month
$3.03 $5.05
from $4.85 now $3.08
-$1.77 (-36.49%)
This year
$2.98 $6.21
from $5.80 now $3.08
-$2.72 (-46.90%)

Price & Performance

-1.18 (-27.70%) / 6M

$2.84$4.00$5.15$6.31May 4Aug 5Nov 4

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 71.2% away from all-time highs of $10.69
  • COYA is down 47% since the beginning of the year
  • COYA is down 47% over the past 12 months
  • COYA is down 36% over the past 1 month
  • 6% of all COYA investors are betting against COYA

COYA reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -47.4%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.28
Earnings momentum +17.6% Quarterly EPS growth
Quarterly change +17.6%

Valuation

P/E ratio N/A
Enterprise value $29.8M
Beta 0.94

Balance sheet & scale

IncomeN/A
Revenue$8.0M
Cash$43.2M
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $72.3M

Coya Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in developing proprietary new therapies to enhance the function of regulatory T cells. Its pipeline includes Treg Modifying Biologics, Allogeneic Treg-Derived Exosomes, and Autologous Treg Cell Therapy. The company was founded by Howard Berman in 2020 and is headquartered in Houston, TX.

Competitor comparison

TickerCompany PriceChange
REGN Regeneron Pharmaceuticals, Inc. $930.67 -4.39%
IQV IQVIA Holdings Inc $263.79 +0.46%
CRL Charles River Laboratories International, Inc. $326.29 -7.27%
ICLR ICON Plc $203.11 -0.32%
IT Gartner, Inc. $207.19 +1.45%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.